Linzess Shortage Update: What Patients Need to Know in 2026

If you've been searching online for a "Linzess shortage" update, you're not alone. Thousands of patients prescribed Linzess (linaclotide) for IBS with constipation (IBS-C) or chronic idiopathic constipation (CIC) have reported difficulty filling their prescriptions. Here's the most current status of Linzess availability and what it means for you in 2026.

Is Linzess in a Shortage in 2026?

The short answer: No, Linzess is not in an official FDA drug shortage as of 2026. The FDA Drug Shortages Database and the American Society of Health-System Pharmacists (ASHP) shortage list do not currently include linaclotide (Linzess). The drug is manufactured by AbbVie in partnership with Ironwood Pharmaceuticals and has been on the market since 2012 with no reported manufacturing disruptions.

However, "not in a shortage" doesn't mean every patient can easily fill their prescription. Here's why the confusion exists and what's actually driving access problems.

Why Do Patients Think There's a Shortage?

When patients can't fill a prescription, it feels like a shortage—even when the cause is different. For Linzess, the access barriers are primarily:

• High cost and brand-only status: Linzess has no generic. Retail price runs $680–$736 per 30-day supply. With no cheaper alternative yet available (generic expected 2029–2030), this shuts out uninsured or underinsured patients.
• Inconsistent pharmacy stocking: Because Linzess is expensive, smaller pharmacies may not keep it on hand. Patients who've always filled at a neighborhood pharmacy may find it's not stocked there.
• Insurance prior authorization: Many plans require prior authorization before covering Linzess. Waiting for approval can leave patients without medication for days to weeks.
• Step therapy requirements: Some insurance plans require patients to try and fail cheaper drugs first before covering Linzess, which can create significant delays.

Current Linzess Availability in 2026

Linzess comes in three strengths—72 mcg, 145 mcg, and 290 mcg—and all three are commercially available. The drug's manufacturer, AbbVie, reports 98% of commercial insurance plans cover the medication. Larger chain pharmacies (CVS, Walgreens, Walmart, Costco) typically stock Linzess more reliably than independent pharmacies.

GoodRx and SingleCare price data indicate Linzess is being filled regularly at participating pharmacies nationwide, confirming that supply—not a manufacturing shortage—is not the problem. The issue is access, not availability.

What About the Linzess Generic Timeline?

One reason access challenges won't go away soon: no generic is coming until at least 2029. Teva Pharmaceuticals has a licensing agreement to market a generic linaclotide 72 mcg version starting March 31, 2029. Generics for the 145 mcg and 290 mcg doses are expected by early 2030. Until then, patients are limited to the brand-name product.

What Can Patients Do Right Now?

If you're struggling to fill your Linzess prescription, here are your best options:

1. Find a pharmacy with it in stock: medfinder will call pharmacies near you and text you which ones have Linzess available.
2. Use savings programs: The Linzess Savings Program from AbbVie can reduce your cost to $30/month with commercial insurance (max $2,280/year savings). The AbbVie Patient Assistance Foundation provides free medication to qualifying uninsured patients.
3. Appeal your prior authorization: If insurance denied coverage, work with your doctor to submit a medical necessity letter or file an appeal. Most PA approvals are processed within 72 hours.
4. Consider alternatives: Trulance, Amitiza (generic lubiprostone), and Motegrity treat similar conditions. See our Linzess alternatives guide for details.

The Bottom Line for 2026

Linzess is not in a shortage, but access barriers—primarily cost, insurance requirements, and inconsistent pharmacy stocking—make it genuinely difficult for many patients to fill. Understanding these barriers and using the tools available to work around them is the key to getting the medication you need.